Optimizing R&D and CMR functions for new therapy area expansion

CASE STUDY

Successful implementation of our recommended R&D and Clinical/Medical/Regulatory
operational changes in Northern European region and, subsequently,
adopted across entire European organisation.

3 month project.

INNOSTRAT KEY DELIVERABLES AND TIMELINES

FEEDBACK FROM OUR CLIENT

“We were in an unfamiliar and uncomfortable situation of going into totally new therapy areas that we knew very little about. InnoStrat helped us to navigate the many unknowns from an execution, skills-profiling and organisational point of view.”
Regional Medical Director
“Building on their thorough audit of our Northern European operations, InnoStrat was able to recommend the best talent profile with the right therapy-area expertise and professional capacity to lead the Clinical and Medical teams and interact with global development functions.”
Regional Medical Director
“Based on InnoStrat’s advice, we decided to restructure our entire European organization. This meant empowering our general managers to take responsibility not just for commercial results but also for successful local execution of clinical trials in the new therapy areas – which in turn drives commercial results 3-5 years later.”
Regional Medical Director
Our company is credit worthy according to Bisnode's credit assessment system that is based on a number of decision rules. This credit rating is updated on a daily basis, and always shows the current rating and date.